ID: ALA4213525

Max Phase: Preclinical

Molecular Formula: C12H14ClNS

Molecular Weight: 203.31

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cl.NCc1ccc(Cc2cccs2)cc1

Standard InChI:  InChI=1S/C12H13NS.ClH/c13-9-11-5-3-10(4-6-11)8-12-2-1-7-14-12;/h1-7H,8-9,13H2;1H

Standard InChI Key:  BRDMSBXGZSSVJT-UHFFFAOYSA-N

Associated Targets(Human)

Ubiquitin carboxyl-terminal hydrolase 2 8818 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 203.31Molecular Weight (Monoisotopic): 203.0769AlogP: 2.80#Rotatable Bonds: 3
Polar Surface Area: 26.02Molecular Species: BASEHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.30CX LogP: 3.10CX LogD: 1.23
Aromatic Rings: 2Heavy Atoms: 14QED Weighted: 0.82Np Likeness Score: -1.40

References

1. Tomala MD, Magiera-Mularz K, Kubica K, Krzanik S, Zieba B, Musielak B, Pustula M, Popowicz GM, Sattler M, Dubin G, Skalniak L, Holak TA..  (2018)  Identification of small-molecule inhibitors of USP2a.,  150  [PMID:29529503] [10.1016/j.ejmech.2018.03.009]

Source